| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.05T | 988.77B | 955.58B | 922.68B | 854.37B | 842.67B |
| Gross Profit | 140.92B | 133.27B | 132.56B | 130.13B | 131.90B | 140.00B |
| EBITDA | 39.23B | 34.19B | 36.43B | 36.70B | 37.51B | 37.02B |
| Net Income | 16.82B | 13.10B | 15.55B | 16.98B | 19.12B | 20.20B |
Balance Sheet | ||||||
| Total Assets | 549.53B | 467.01B | 462.57B | 436.76B | 413.12B | 394.09B |
| Cash, Cash Equivalents and Short-Term Investments | 21.61B | 20.99B | 23.23B | 22.74B | 47.99B | 50.95B |
| Total Debt | 102.62B | 62.54B | 43.36B | 45.67B | 37.85B | 39.58B |
| Total Liabilities | 251.96B | 180.69B | 177.24B | 167.50B | 150.38B | 146.44B |
| Stockholders Equity | 296.91B | 285.61B | 284.69B | 268.69B | 262.14B | 247.06B |
Cash Flow | ||||||
| Free Cash Flow | -6.65B | -9.35B | 14.76B | -8.50B | 9.43B | 31.18B |
| Operating Cash Flow | 15.05B | 10.02B | 29.39B | 3.95B | 18.47B | 40.86B |
| Investing Cash Flow | -23.63B | -20.64B | -16.01B | -22.93B | -11.25B | -10.84B |
| Financing Cash Flow | 10.43B | 7.47B | -13.28B | -6.84B | -10.65B | -21.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥491.90B | 15.17 | 9.86% | 2.58% | 1.08% | 2.71% | |
67 Neutral | ¥59.29B | 7.19 | 6.48% | 2.27% | 1.46% | ― | |
64 Neutral | ¥299.52B | 12.27 | ― | 2.61% | 6.54% | 15.08% | |
63 Neutral | ¥692.97B | 15.19 | 6.04% | 2.04% | 5.55% | 27.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | ¥5.59B | 4.87 | ― | ― | -3.27% | -108.33% | |
37 Underperform | ¥2.01B | 5.43 | ― | ― | -2.97% | -6.82% |